BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 19432109)

  • 21. [CBO guideline 'Osteoporosis' (second revision].
    Pols HA; Wittenberg J
    Ned Tijdschr Geneeskd; 2002 Jul; 146(29):1359-63. PubMed ID: 12162173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Underdiagnosis and under-treatment of osteoporosis following fragility fracture.
    Aboyoussef M; Vierkoetter KR
    Hawaii Med J; 2007 Jul; 66(7):185-7. PubMed ID: 17879856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of pharmaceutical intervention in the treatment of osteoporosis and prevention of fracture].
    Nakamura T
    Nihon Rinsho; 2009 May; 67(5):903-8. PubMed ID: 19432107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of vitamin D in the treatment of osteoporosis in the elderly].
    Pfeifer M; Minne HW
    Med Klin (Munich); 2006 Jun; 101 Suppl 1():15-9. PubMed ID: 16826364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hip fracture patients are not treated for osteoporosis: a call to action.
    Harrington JT; Broy SB; Derosa AM; Licata AA; Shewmon DA
    Arthritis Rheum; 2002 Dec; 47(6):651-4. PubMed ID: 12522840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM; Valeriano J; Vasey FB; Carter JD
    J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada.
    CMAJ; 1996 Oct; 155(8):1113-33. PubMed ID: 8873639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Primary osteoporosis--its diagnosis and treatment].
    Inaba M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():485-9. PubMed ID: 18161153
    [No Abstract]   [Full Text] [Related]  

  • 30. Anabolic therapy for osteoporosis.
    Bilezikian JP
    Int J Fertil Womens Med; 2005; 50(2):53-60. PubMed ID: 16334411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of SERMs on bone health. Effects of raloxifene and bisphosphonate on bone quality in osteoporosis: collagen cross-links, mineralization, and bone strength].
    Saito M
    Clin Calcium; 2010 Mar; 20(3):345-54. PubMed ID: 20190364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoporosis risk in premenopausal women.
    Vondracek SF; Hansen LB; McDermott MT
    Pharmacotherapy; 2009 Mar; 29(3):305-17. PubMed ID: 19249949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteoporosis prevention and treatment.
    Sambrook PN; Eisman JA
    Med J Aust; 2000 Mar; 172(5):226-9. PubMed ID: 10776395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteoporosis management.
    Rozenberg S; Vandromme J; Ayata NB; Filippidis M; Kroll M
    Int J Fertil Womens Med; 1999; 44(5):241-9. PubMed ID: 10569453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis and treatment of immobilization osteoporosis].
    Inoue D
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():514-9. PubMed ID: 18159714
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study.
    Silverman SL; Shen W; Minshall ME; Xie S; Moses KH
    J Rheumatol; 2007 Jan; 34(1):140-4. PubMed ID: 17216681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapeutic agents for disorders of bone and calcium metabolism: Minodronic acid hydrate].
    Miki T; Minamide T
    Clin Calcium; 2007 Jan; 17(1):18-22. PubMed ID: 17211089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug insight: Existing and emerging therapies for osteoporosis.
    Mulder JE; Kolatkar NS; LeBoff MS
    Nat Clin Pract Endocrinol Metab; 2006 Dec; 2(12):670-80. PubMed ID: 17143314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
    AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [First choice drug for treatment of osteoporosis and the strategic points for choice of drugs].
    Soen S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():325-8. PubMed ID: 18159713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.